Next Article in Journal
Blue Laser (450 nm) in the Treatment of Port Wine Stains and Telangiectasia
Next Article in Special Issue
Male Sex Is Associated with Higher Mortality and Increased Risk for Complications after Surgical Treatment of Proximal Humeral Fractures
Previous Article in Journal
Variable Expressivity in Type 2 Familial Partial Lipodystrophy Related to R482 and N466 Variants in the LMNA Gene
Previous Article in Special Issue
The Role of Hip Joint Clearance Discrepancy as Other Clinical Predictor of Reinjury and Injury Severity in Hamstring Tears in Elite Athletes
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Impact of the 1st and 2nd Wave of the COVID-19 Pandemic on Primary or Revision Total Hip and Knee Arthroplasty—A Cross-Sectional Single Center Study

by
Sebastian Simon
1,2,
Bernhard J.H. Frank
1,
Alexander Aichmair
1,2,
Philip P. Manolopoulos
1,
Martin Dominkus
2,3,
Eva S. Schernhammer
4 and
Jochen G. Hofstaetter
1,2,*
1
Michael Ogon Laboratory for Orthopaedic Research, Orthopaedic Hospital Vienna-Speising, Speisinger Straße 109, 1130 Vienna, Austria
2
2nd Department, Orthopaedic Hospital Vienna-Speising, Speisinger Straße 109, 1130 Vienna, Austria
3
School of Medicine, Sigmund Freud University Vienna, Freudplatz 1, 1020 Vienna, Austria
4
Department of Epidemiology, Medical University of Vienna, Kinderspitalgasse 15, 1090 Vienna, Austria
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2021, 10(6), 1260; https://doi.org/10.3390/jcm10061260
Submission received: 4 February 2021 / Revised: 12 March 2021 / Accepted: 16 March 2021 / Published: 18 March 2021

Abstract

:
The aim of this study was to evaluate the number of primary and revision total joint arthroplasties (TJA/rTJA) in 2020 compared to 2019. Specifically, the first and the second waves of the COVID-19 pandemic were evaluated as well as the pre-operative COVID-19 test. A cross-sectional single-center study of our prospectively maintained institutional arthroplasty registry was performed. The first COVID-19 wave and the second COVID-19 wave led to a socioeconomic lockdown in 2020. Performed surgeries, cause of revision, age, gender, and American Society of Anesthesiologists-level were analyzed. Preoperative COVID-19 testing was evaluated and nationwide COVID-19 data were compared to other countries. In 2020, there was a decrease by 16.2% in primary and revision TJAs of the hip and knee compared to 2019. We observed a reduction of 15.8% in primary TJAs and a reduction of 18.6% on rTJAs in 2020 compared to 2019. There is an incline in total hip arthroplasties (THAs) and a decline in total knee arthroplasties (TKAs) comparing 2019 to 2020. During the first wave, there was a reduction in performed primary TJAs of 86%. During the second wave, no changes were observed. This is the first study quantifying the impact of the COVID-19 pandemic on primary and revision TJAs regarding the first and second wave.

1. Introduction

The outbreak of the corona-virus-disease-2019 (COVID-19), caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in 2019, focused all resources on the coronavirus disease, placing an additional burden on healthcare systems worldwide [1]. The first wave of the COVID-19 pandemic arose in Europe and America during March and April 2020. The second wave, in the fall/winter of 2020, had a substantial higher case number compared to the first one [2,3].
The COVID-19 pandemic has an enormous direct and indirect impact on all healthcare systems [4,5]. Elective surgeries were cancelled, cancer patients endured a delay in care, treatment and screening and even trauma patients had a delay in surgical treatment [6,7,8]. Substantial cancellations and delays of a large number of total hip arthroplasties (THAs) and total knee arthroplasties (TKAs) was observed during the pandemic [9,10]. So far, only general strategies and estimations about the impact of COVID-19 have been published [10,11,12]. However, the COVID-19 pandemic had a substantial impact on orthopedics in 2020. Thus, there is an urgent need for detailed analyses on the COVID-19 pandemic impact on knee and hip arthroplasty in 2020.
Austria gained international attention as a potential center of coronavirus spread due to its geographical location in the middle of Europe and its high incidence rates of COVID-19 during the second wave, with a daily maximum of 106 new cases per 100,000 inhabitants [13]. Due to rising numbers of disease cases, the Austrian government imposed three socioeconomic lockdowns in March, November, and December 2020.
The aim of the present study was to analyze the number of primary and revision total hip and knee arthroplasty performed in 2020 compared to 2019 at the Orthopedic Hospital, Vienna-Speising, Austria, which implants, on average, over 2800 primary and revision TKAs and total joint arthroplasties (TJAs) per year. We evaluated the results of our preoperative COVID tests in 2020.

2. Materials and Methods

2.1. Study Population

This cross-sectional single center study was approved by the Austrian, Vienna Vinzenz group Ethical Review Board (EK 56/2020). The study period was defined as the time between 1 January 2019 and 31 December 2020. Patients who consecutively underwent primary or revision total joint arthroplasty (TJAs/rTJAs) of the hip or knee joint were included. All surgeries were performed at a single orthopedic tertiary care center in Vienna. Overall, 5268 patients (2866 from 2019 and 2402 from 2020) were included in this study. Patient data were retrieved from a prospectively maintained institutional arthroplasty registry, which comprises information on patient age, gender, American Society of Anaesthesiologists (ASA)-level, and type of surgery.

2.2. Institutional COVID-19 Screening

According to an institutional standard, on 22 March 2020, all patients undergoing total joint replacement were preoperatively screened for COVID-19 using polymerase-chain-reaction (PCR) tests. Since calendar week 46, screening was performed using a SARS-CoV-2 Rapid Antigen (Ag) Test (Abbott-Panbio™, Fairmed®, Zug, Switzerland,). A positive Ag test was confirmed by an additional PCR test. Patients who tested positive for SARS-CoV-2 were not admitted and their operations were postponed (Figure 1b).

2.3. Austrian COVID-19 Data

Sources for data retrieval were the European Center for Disease Prevention and Control (ECDC) and the COVID-19 data repository of the Center for Systems Science and Engineering (CSSE) at the Johns Hopkins University. This data is sourced from governments and national and subnational agencies across the world. Daily numbers of SARS-CoV-2 cases were retrieved from https://ourworldindata.org/coronavirus-source-data (last accessed: 25 January 2021). For the purpose of the recent study, the data was presented as daily incidence per 100,000. The mean of daily new cases were calculated for each calendar week. For the maximum evaluation, we took the daily maximum of the contributing calendar week.
The distribution of incident COVID-19 cases by gender was retrieved from Austria’s governmental COVID-19 dashboard for public information, as published and updated daily on https://info.gesundheitsministerium.at (last accessed: 25 January 2021) by the Austrian Federal Ministry of Social Affairs, Health, Care, and Consumer Protection (AGES).
Austria experienced two COVID-19 waves in 2020. In this study, the two waves were each defined as eight-week time periods. The first wave arose between calendar weeks 12–20 and the second wave between calendar weeks 45–53. As a result, the Austrian government imposed three socioeconomic lockdowns. The first one during SARS-CoV-2 wave one, between calendar weeks 12–20, had a duration of eight weeks, and the second and third during SARS-CoV-2 wave two, between calendar weeks 45–49 and 52–54, had a duration of five and three weeks, respectively.

2.4. Statistical Analyses

We employed descriptive statistics, using means (M), standard deviations (SD), median (Md), interquartile and minimum (min), and maximum (max) ranges to present continuous study parameters and frequencies and percentages for categorical variables.
We calculated means of the number of performed surgeries (TKAs, THAs, revision total knee arthroplasties (rTKAs), and revision total hip arthroplasties (rTHAs)) in 2019 and 2020 per each calendar week, 1–53. The ratio of revision to primary surgery was also calculated, and causes for revision surgery were summarized for each period and year.
Comparing study groups, Mann–Whitney U-testing for metric variables was conducted. For nominally scaled variables, we used chi-squared testing based on crosstabs; p-values < 0.05 were considered statistically significant. All analyses were performed using IBM-SPSS® version 25 (Armonk, NY, USA).

3. Results

3.1. COVID-19 Demographics

Countries such as Austria, Germany, Italy, the United Kingdom (UK), and the United States of America (USA) have been strongly affected by the SARS-CoV2 pandemic. In Austria, the daily new SARS-CoV2 cases peaked with a maximum of 15 per 100,000 inhabitants during the first wave and 100 per 100,000 inhabitants during the second wave. In comparison, in Germany, Italy, the UK, and the USA, the first wave had a peak between 8–11 daily new SARS-CoV2 cases per 100,000 inhabitants and the second wave had a peak between 60–80 daily new SARS-CoV2 cases (Figure 1a).
The maximum peak of daily new cases during the first wave peaked at 14.7 per 100,000 during calendar week 13. The maximum peak of daily new cases during the second wave peaked at 106.4 per 100,000 during calendar week 46 (Figure 1a).
In total, there were 361,441 (51.4% female and 48.6% male) SARS-CoV2 cases reported in Austria in 2020. AGES defines COVID-19 deaths as: “COVID-19 death is defined —for surveillance purposes—as one laboratory-confirmed case of COVID-19 resulting in death, where the status recovered has not been present between the status disease and the status death”. There were 6238 (47.1% female and 52.9% male) COVID-19 deaths, which results in a mortality rate of 1.7%. Overall, 16.8% of SARS-CoV2 patients were over 65 years old, but 93.7% of COVID-19 deaths occurred in patients over 65 years old, equaling a mortality rate of 9.5%. In total, 65.5% of our patients were over 65 years. The detailed gender and age distribution of COVID-19 cases and patients is illustrated in Figure 2a,b.

3.2. Institutional Results

In 2020, there was a total reduction of 16.2% (n = 464) in primary and revision TJAs of the hip and knee compared to 2019 (2402 vs. 2866). Moreover, a reduction of 15.8% (n = 388) in primary TJAs (2457 vs. 2069) and 18.6% (n = 76) in revision TJAs (409 vs. 333) was observed between 2019 and 2020, as illustrated in Figure 3a,b. There was a significant relative incline (p < 0.010) of THA in 2020 compared to 2019 and a significant relative decline (p < 0.049) of TKA in 2020 compared to 2019 (Table 1).
While the number of performed rTJAs remained relatively stable during the study period, the mean ratio of revision vs. primary surgery increased from 0.17 (1.7 revisions vs. 10 primary) in 2019 to 0.31 (3.1 revisions vs. 10 primary) in 2020 (Figure 3c). The causes of rTKAs did not change, while, for rTHAs, the number of septic revisions significantly decreased (p < 0.002) and the aseptic loosening revisions significantly increased (p < 0.015) during 2020 (Table 1). There were significantly higher ASA-levels in rTJAs (p < 0.001), rTKA (p = 0.049), and rTHA (p = 0.001) in 2019 compared to 2020. Overall, there was no significant difference in age and gender between 2019 and 2020 (Table 1).
During the first COVID-19 wave in 2020, a total of 60 primary TJAs were performed, compared to 428 in the corresponding weeks of 2019, representing a reduction of 86.0% (n = 368). The steepest decline in performed primary TJAs during the first COVID-19 wave was noted from calendar week 11 (n = 49) to calendar week 12 (n = 2), indicating a drop by 96.0% from one week to the other (Figure 3a). The number of rTJAs dropped by 31.0% (n = 27). At the same time, the ratio of revision to primary surgery peaked at 3.5 (35 revisions vs. 10 primary). The overall ratio of revision to primary surgery during the first lockdown was 1.15 (11.5 revisions vs. 10 primary) (Figure 3a–c).
During the second COVID-19 wave, a total of 376 primary TJAs were performed, compared to 370 in the corresponding weeks of 2019, resulting in an increase of 1.6% (n = 6). The number of rTJAs dropped by 3.4% (n = 2). In parallel, the ratio of revision vs. primary surgery peaked at 0.25 (2.5 revisions vs. 10 primary) in calendar week 53. The ratio of revision vs. primary surgery throughout the entire duration of the second wave was 0.17 (1.7 revisions vs. 10 primary) (Figure 3a–c). In our center, a total of 10,635 COVID-19 tests were performed in 2020. Of these, 63 (0.6%) had a positive result (Figure 1b). The overall test data from Austria showed a 9.7% positive test rate in 2020.

4. Discussion

This is the first study giving detailed information about the impact of the COVID-19 pandemic on a public tertiary care orthopedic center in 2020, concerning TJAs and rTJAs of the hip and knee joint. We analyzed the number of patients in 2020 compared to 2019. In 2020, a reduction of 16.2% of primary and revision TJAs of the hip and knee occurred, compared to 2019.
The significant differences between the relative incline of THAs and the relative decline of TKAs in 2020 compared to 2019 suggest that a painful hip is more debilitating than a painful knee. Due to the incline of THAs and the decline of TKAs, there is no significant difference in the total number of TJAs. The decline of rTJAs in 2020 is as a result of the reduction of performed primary TJAs in 2020. Between 2019 and 2020, no changes in institutional standard treatment protocol were made. Therefore, the observed changes between 2019 and 2020 in the relative amount of septic and aseptic loosening revisions are not entirely clear and need further research. Moreover, there was a significantly lower ASA-level in rTJAs, rTKAs, and rTHAs in 2020. This could be explained by the fact that only COVID-19 symptom-free and healthy patients underwent elective revision surgery.
Countries worldwide had instituted either full or partial lockdowns. Austria, a country with a population of approximately 9 million, gained international attention for its early coronavirus spread during the first wave and high local incidence rates of COVID-19 during the second wave of the pandemic [14]. The COVID-19 pandemic has affected all aspects of surgical procedures and scheduling, where elective cases were postponed during the first wave of the SARS-CoV-2 pandemic [15,16,17]. Patients suffered from a care delay, and the surgical volume for cancer surgeries and emergency and general surgery procedures, as well as coronary syndrome interventions, dropped substantially during the first wave of the pandemic [7,8,18,19]. In the study by Brown et al., comparing 15 orthopedic institutions in the USA between May and June 2020, 86% of knee and hip arthroplasty operations were postponed or cancelled [20]. All those findings match to the 86% (-368 primary TJAs) decline during the first wave of surgical procedures described in this study. So far, there is no literature available, neither for the detailed numbers of cancellation during the whole SARS-CoV-2 pandemic, nor for the comparison of the first and second SARS-CoV-2 wave in 2020.
There are different reasons for postponed patients waiting for TJAs during the pandemic. During the first wave of the COVID-19 pandemic the federal ministry for Social Affairs, Health, Care, and Consumer Protection of Austria announced their intention to preserve personal protective equipment (PPE) supplies for the care of patients with COVID-19, followed by a massive reduction of elective surgeries. It also enabled recovery areas in operation theatres to be repurposed as overflow intensive care units (ICUs). As our center was part of this plan, post COVID-19 patients were admitted for their recovery. Patient uncertainty, a short preparatory period, and the impact of lockdown messages and advice regarding self-isolation were other reasons for the decline of 368 primary TJAs during the first wave in 2020 compared to the corresponding weeks of 2019. Therefore, the ratio of revision vs. primary surgery increased.
During the second wave, governmental and hospital managements were better prepared regarding the amount of PPE and strategies for the care of COVID-19 and non-COVID-19 patients. During the whole COVID-19 pandemic, our tertiary care center was declared a COVID-19 free institution. When a patient tested positive for SARS-CoV-2, they were not admitted and the scheduled surgery was postponed. Moreover, our center followed the guidelines from the European Society of Sports Traumatology, Knee Surgery, and Arthroscopy (ESSKA) for resumption of orthopedic services. Elective surgery should be performed in COVID-free facilities, hospital stay should be as short as possible, and surgeries should be postponed at the slightest suspicion of a SARS-CoV-2 infection [21,22]. Furthermore, safety guidelines, such as patient and staff weekly testing strategies, as well as the mandatory use of filtering facepiece masks (FFP-2) throughout the facilities were implemented. Most patients undergoing elective surgical procedures do not need ICU resources, and the rapid turnover of elective surgery cases also minimizes the extra pressure on the already strained resources [17]. Therefore, there was almost the same amount of primary TJAs during the second wave in 2020 and the corresponding weeks of 2019.
Regular surgeries recommenced after the cessation of the first lockdown and the relevant recommendations of the Austrian Ministry for Health. It took more than three months after the reduction of TJAs to approach pre-pandemic conditions with regard to TJAs. This is a much shorter time-period than the estimations performed from Jain et al. in US calculate scenarios, in which it would take approximately 7–16 months until the health-care system would be able to revert to a 90% pre-pandemic forecasted volume [23].
The low positive rate (0.6%) of performed SARS-CoV-2 tests in our center is another reason to pursue an elective surgery program. One reason for the low positive rate in our center (0.6%) compared to the overall SARS-CoV-2 test positive rate of Austria (9.7%) is that only COVID-19 symptom-free and healthy patients underwent testing following elective surgery.
Translational research results from the previous wave/s are required to prepare for a potential third wave, but also for other pandemics in the future. The main limitation of this study is its single-center design. The COVID-19 impact on a tertiary care institution will not represent the impact on other orthopedic divisions. Multi-center studies are needed to evaluate the total impact of the COVID-19 pandemic on health care systems and assess the amount of the total backlog and the possible changes in patient’s mortality and morbidity.

5. Conclusions

Our study demonstrated that the COVID-19 pandemic has had a substantial impact on a public orthopedic tertiary care center, especially during the first COVID-19 wave. Adopting specific strategies for continuing elective surgery, ensuring, at the same time, patient and personnel safety, may allow care centers to perform TJAs at the same pre-pandemic conditions.

Author Contributions

Conceptualization, S.S., A.A., and J.G.H.; methodology, S.S., A.A., E.S.S., B.J.H.F., and J.G.H.; validation, S.S., A.A., E.S.S., M.D., B.J.H.F., J.G.H., and P.P.M.; formal analysis, S.S. and B.J.H.F.; resources, S.S., A.A., M.D., B.J.H.F., J.G.H., and P.P.M.; data curation, E.S.S., P.P.M., and S.S.; writing—original draft preparation, S.S., B.J.H.F., and P.P.M.; writing—review and editing, A.A., E.S.S., M.D., B.J.H.F., J.G.H., and P.P.M.; visualization, S.S., B.J.H.F., and J.G.H.; supervision, A.A., E.S.S., and J.G.H.; project administration, S.S. and J.G.H. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The Austrian, Vienna Vinzenz group Ethical Review Board approved the study (EK 56/2020).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

Daily numbers of SARS-CoV-2 cases were retrieved from https://ourworldindata.org/coronavirus-source-data (last accessed: 25 January 2021). The distribution of incident COVID-19 cases by gender was retrieved from Austria’s governmental COVID-19 dashboard for public information, as published and daily updated on https://info.gesundheitsministerium.at by the Austrian Federal Ministry of Social Affairs, Health, Care, and Consumer Protection (last accessed: 25 January 2021).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Saglietto, A.; D’Ascenzo, F.; Zoccai, G.B.; De Ferrari, G.M. COVID-19 in Europe: The Italian lesson. Lancet 2020, 395, 1110–1111. [Google Scholar] [CrossRef]
  2. Pedro, S.A.; Ndjomatchoua, F.T.; Jentsch, P.; Tchuenche, J.M.; Anand, M.; Bauch, C.T. Conditions for a Second Wave of COVID-19 Due to Interactions Between Disease Dynamics and Social Processes. Front. Phys. 2020, 9, 8. [Google Scholar] [CrossRef]
  3. Hills, M. Covid-19 in the US: Bleak Winter Ahead as Deaths Surge. Available online: https://www.bbc.com/news/world-us-canada-54966531 (accessed on 12 December 2020).
  4. Goldstein, J.R.; Lee, R.D. Demographic perspectives on the mortality of COVID-19 and other epidemics. Proc. Natl. Acad. Sci. USA 2020, 117, 22035–22041. [Google Scholar] [CrossRef] [PubMed]
  5. Kuderer, N.M.; Choueiri, T.K.; Shah, D.P.; Shyr, Y.; Rubinstein, S.M.; Rivera, D.R.; Shete, S.; Hsu, C.-Y.; Desai, A.; de Lima Lopes, G.; et al. Clinical impact of COVID-19 on patients with cancer (CCC19): A cohort study. Lancet 2020, 395, 1907–1918. [Google Scholar] [CrossRef]
  6. Egol, K.A.; Konda, S.R.; Bird, M.L.; Dedhia, N.; Landes, E.K.; Ranson, R.A.; Solasz, S.J.; Aggarwal, V.K.; Bosco, J.A., III; Furgiuele, D.L.; et al. Increased mortality and major complications in hip fracture care during the COVID-19 pandemic: A New York city perspective. J. Orthop. Trauma 2020, 34, 395–402. [Google Scholar] [CrossRef]
  7. Dinmohamed, A.G.; Visser, O.; Verhoeven, R.H.; Louwman, M.W.; van Nederveen, F.H.; Willems, S.M.; Merkx, M.A.; Lemmens, V.E.; Nagtegaal, I.D.; Siesling, S. Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands. Lancet Oncol. 2020, 21, 750–751. [Google Scholar] [CrossRef]
  8. Fu, S.J.; George, E.L.; Maggio, P.M.; Hawn, M.; Nazerali, R. The Consequences of Delaying Elective Surgery: Surgical Perspective. Ann. Surg. 2020, 272, e79–e80. [Google Scholar] [CrossRef]
  9. Wilson, J.M.; Schwartz, A.M.; Grissom, H.E.; Holmes, J.S.; Farley, K.X.; Bradbury, T.L.; Guild, G.N. Patient Perceptions of COVID-19-Related Surgical Delay: An Analysis of Patients Awaiting Total Hip and Knee Arthroplasty. HSS J.® 2020, 16, 45–51. [Google Scholar] [CrossRef] [PubMed]
  10. Bedard, N.A.; Elkins, J.M.; Brown, T.S. Effect of COVID-19 on Hip and Knee Arthroplasty Surgical Volume in the United States. J. Arthroplast. 2020, 35, S45–S48. [Google Scholar] [CrossRef] [PubMed]
  11. Thaler, M.; Khosravi, I.; Hirschmann, M.T.; Kort, N.P.; Zagra, L.; Epinette, J.A.; Liebensteiner, M.C. Disruption of joint arthroplasty services in Europe during the COVID-19 pandemic: An online survey within the European Hip Society (EHS) and the European Knee Associates (EKA). Knee Surg. Sport Traumatol. Arthrosc. 2020, 28, 1712–1719. [Google Scholar] [CrossRef]
  12. Athey, A.G.; Cao, L.; Okazaki, K.; Zagra, L.; Castelli, C.C.; Kendoff, D.O.; Kerr, J.M.; Yates, A.J.; Stambough, J.B.; Sierra, R.J. Survey of AAHKS International Members on the Impact of COVID-19 on Hip and Knee Arthroplasty Practices. J. Arthroplast. 2020, 35, S89–S94. [Google Scholar] [CrossRef] [PubMed]
  13. Lee, H.K.; Knabl, L.; Pipperger, L.; Volland, A.; Furth, P.A.; Kang, K.; Smith, H.E.; Bellmann, R.; Bernhard, C.; Kaiser, N.; et al. Immune transcriptomes of highly exposed SARS-CoV-2 asymptomatic seropositive versus seronegative individuals from the Ischgl community. Sci. Rep. 2020, 11, 1–10. [Google Scholar]
  14. Kreidl, P.; Schmid, D.; Maritschnik, S.; Richter, L.; Borena, W.; Genger, J.-W.; Popa, A.; Penz, T.; Bock, C.; Bergthaler, A.; et al. Emergence of coronavirus disease 2019 (COVID-19) in Austria. Wien. Klin. Wochenschr. 2020, 132, 645–652. [Google Scholar] [CrossRef]
  15. DeKeyser, G.J.; Brodke, D.S.; Saltzman, C.L.; Lawrence, B.D. Response to the Coronavirus Disease 2019 Pandemic by the Spine Division at a Level-I Academic Referral Center. J. Am. Acad. Orthop. Surg. 2020, 28, 1003–1008. [Google Scholar] [CrossRef]
  16. De Caro, F.; Hirschmann, T.M.; Verdonk, P. Returning to orthopaedic business as usual after COVID-19: Strategies and options. Knee Surg. Sport Traumatol. Arthrosc. 2020, 28, 1699–1704. [Google Scholar] [CrossRef]
  17. Ambrosio, L.; Vadalà, G.; Russo, F.; Papalia, R.; Denaro, V. The role of the orthopaedic surgeon in the COVID-19 era: Cautions and perspectives. J. Exp. Orthop. 2020, 7, 1–9. [Google Scholar] [CrossRef]
  18. Mari, G.; Giordano, R.; Uccelli, M.; Cesana, G.; Olmi, S.; Ferrari, G.C.; Origi, M.; Maggioni, D.; Colletti, G.; Costanzi, A. Do We Really Know How Much the Covid-19 Pandemic Affected the Surgical Practice in Northern Italy? A Multi-Center Comparative Study and Cost Analysis. Chirurgia 2020, 115, 469. [Google Scholar] [CrossRef]
  19. Nef, H.M.; Elsässer, A.; Möllmann, H.; Abdel-Hadi, M.; Bauer, T.; Brück, M.; Eggebrecht, H.; Ehrlich, J.R.; Ferrari, M.W.; CoVCAD–Study Group; et al. Impact of the COVID-19 pandemic on cardiovascular mortality and catherization activity during the lockdown in central Germany: An observational study. Clin. Res. Cardiol. 2020, 110, 292–301. [Google Scholar] [CrossRef] [PubMed]
  20. Brown, T.S.; Bedard, N.A.; Rojas, E.O.; Anthony, C.A.; Schwarzkopf, R.; Stambough, J.B.; Nandi, S.; Prieto, H.; Parvizi, J.; Bini, S.A.; et al. A BRIEF UPDATE ON THE EFFECT OF THE COVID-19 PANDEMIC ON HIP AND KNEE ARTHROPLASTY PATIENTS IN THE UNITED STATES A Multicenter Update to a Previous Survey Study of Patients Postponed by the Pandemic. Arthroplast. Today 2020, 7, 268–272. [Google Scholar] [CrossRef] [PubMed]
  21. Mouton, C.; Hirschmann, M.T.; Ollivier, M.; Seil, R.; Menetrey, J. COVID-19-ESSKA guidelines and recommendations for resuming elective surgery. J. Exp. Orthop. 2020, 7, 28. [Google Scholar] [CrossRef] [PubMed]
  22. Ow, Z.G.W.; Cheong, C.K.; Chin, Y.H.; Chin, B.Z. A look at the global impact of SARS CoV-2 on orthopedic services. J. Clin. Orthop. Trauma 2020, 12, 33–39. [Google Scholar] [CrossRef] [PubMed]
  23. Jain, A.; Jain, P.; Aggarwal, S. SARS-CoV-2 Impact on Elective Orthopaedic Surgery. J. Bone Jt. Surg. 2020, 102, e68. [Google Scholar] [CrossRef] [PubMed]
Figure 1. COVID-19 cases and performed tests. (a): Daily new cases per 100,000 per calendar week for Austria (AUT), Germany (GER), Italy (ITA), the UK, and the USA. The grey shaded areas visualize the first and the second wave in Austria. (b): Absolute number of performed and positive tests in our center per calendar week. The grey shaded areas visualize the first and the second wave in Austria.
Figure 1. COVID-19 cases and performed tests. (a): Daily new cases per 100,000 per calendar week for Austria (AUT), Germany (GER), Italy (ITA), the UK, and the USA. The grey shaded areas visualize the first and the second wave in Austria. (b): Absolute number of performed and positive tests in our center per calendar week. The grey shaded areas visualize the first and the second wave in Austria.
Jcm 10 01260 g001
Figure 2. COVID-19 deaths and relative number of performed primary and revision total joint arthroplasties (TJAs). (a): Relative number of COVID-19 deaths in Austria per age group. (b): Relative number of primary and revision total joint arthroplasties (TJAs) per age group.
Figure 2. COVID-19 deaths and relative number of performed primary and revision total joint arthroplasties (TJAs). (a): Relative number of COVID-19 deaths in Austria per age group. (b): Relative number of primary and revision total joint arthroplasties (TJAs) per age group.
Jcm 10 01260 g002
Figure 3. Number of performed primary and revision total joint arthroplasties. (a): Absolute numbers of primary TJAs per calendar week, comparing 2019 and 2020. The grey shaded areas visualize the first and the second wave in Austria. (b): Absolute numbers of primary TJAs per calendar week, comparing 2019 and 2020. The grey shaded areas visualize the first and the second wave in Austria. (c): Ratio between the numbers of revision and primary TJAs per calendar week, comparing 2019 and 2020. The grey shaded areas visualize the first and the second wave in Austria.
Figure 3. Number of performed primary and revision total joint arthroplasties. (a): Absolute numbers of primary TJAs per calendar week, comparing 2019 and 2020. The grey shaded areas visualize the first and the second wave in Austria. (b): Absolute numbers of primary TJAs per calendar week, comparing 2019 and 2020. The grey shaded areas visualize the first and the second wave in Austria. (c): Ratio between the numbers of revision and primary TJAs per calendar week, comparing 2019 and 2020. The grey shaded areas visualize the first and the second wave in Austria.
Jcm 10 01260 g003
Table 1. Characteristics of study relevant parameters for surgical procedures in 2019 and 2020 including gender, age, and American Society of Anaesthesiologists (ASA)-level. Frequencies and column percentage of distribution according occurrence of septic, aseptic loosening, Instability/Dislocation, fracture, other septic conditions, abrasion, pain, implant failure, and leg length difference (LLD); ** p ≤ 0.01, * p ≤ 0.05.
Table 1. Characteristics of study relevant parameters for surgical procedures in 2019 and 2020 including gender, age, and American Society of Anaesthesiologists (ASA)-level. Frequencies and column percentage of distribution according occurrence of septic, aseptic loosening, Instability/Dislocation, fracture, other septic conditions, abrasion, pain, implant failure, and leg length difference (LLD); ** p ≤ 0.01, * p ≤ 0.05.
Parameter20192020p-Value
Total TJAsn = 2866n = 2402
Primary TJAs total2457 (85.7%)2069 (86.1%)0.672
  Gender female1552 (63.2%)1330 (64.3%)0.309
       male905 (36.8%)739 (35.7%)
  Age68.1 (±11.4)68.2 (±11.3)0.360
  ASA-level1.97 (±0.46)1.96 (±0.47)0.420
Revision TJAs total409 (14.3%)333 (13.9%)0.672
  Gender female247 (60.4%)191 (57.4%)0.923
       male162 (39.6%)142 (42.6%)
  Age69.3 (±11.7)68.5 (±12.7)0.485
  ASA-level2.21 (±0.53)2.02 (±0.46)<0.001 **
Total TKAsn = 1477n = 1147
Primary TKAs1272 (86.1%)956 (83.3%)0.049 *
  Gender female827 (65.0%)620 (64.9%)0.937
       male445 (35.0%)336 (35.1%)
  Age (years)69.6 (±9.5)69.6 (±9.7)0.751
  ASA-level2.02 (±0.42)2.01 (±0.41)0.642
Revision TKAs205 (13.9%)191 (16.7%)0.049 *
  Gender female123 (60.0%)114 (59.7%)0.915
       male82 (40.0%)77 (40.3%)
  Age (years)71.2 (±9.5)69.9 (±10.7)0.320
  ASA-level2.18 (±0.44)2.07 (±0.41)0.048 *
  Cause of Revision TKAs
     Septic95 (46.3%)88 (46.1%)0.519
     Instability35 (17.1%)33 (17.3%)0.957
     Pain16 (7.8%)24 (13.0%)0.748
     Aseptic loosening28 (13.7%)21 (11.0%)0.276
     Fracture6 (2.9%)8 (4.2%)0.252
     Other aseptic14 (6.8%)8 (4.2%)0.687
     Wear7 (3.4%)5 (2.6%)0.852
     Implant Failure4 (2.0%)4 (2.1%)0.919
Total THAn = 1389n = 1255
Primary THAs1185 (85.3%)1113 (88.7%)0.010 **
  Gender female725 (61.2%)710 (63.8%)0.197
       male460 (38.8%)403 (36.2%)
  Age (years)66.4 (±12.9)66.8 (±12.4)0.582
  ASA-level1.92 (±0.50)1.91 (±0.51)0.715
Revision THAs204 (14.7%)142 (11.3%)0.010 **
  Gender female124 (60.8%)90 (63.4%)0.625
       male80 (39.2%)52 (36.6%)
  Age (years)67.4 (±13.3)66.6 (±14.9)0.320
  ASA-level2.23 (±0.60)1.97 (±0.51)0.001 **
  Cause of Revision THAs
     Septic95 (46.6%)43 (30.3%)0.002 **
     Aseptic loosening50 (24.5%)52 (36.6%)0.015 *
     Dislocation26 (12.7%)24 (16.9%)0.279
     Fracture14 (6.8%)16 (11.3%)0.152
     Other aseptic4 (2.9%)2 (1.4%)0.699
     Wear2 (1.0%)2 (1.4%)0.714
     Pain2 (1.0%)1 (0.7%)0.146
     Implant Failure4 (2.0%)1 (0.7%)0.221
     LLD2 (1.0%)1 (0.7%)0.785
TJA, total joint arthroplasty; THA, total hip arthroplasty; TKA, total knee arthroplasty.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Simon, S.; Frank, B.J.H.; Aichmair, A.; Manolopoulos, P.P.; Dominkus, M.; Schernhammer, E.S.; Hofstaetter, J.G. Impact of the 1st and 2nd Wave of the COVID-19 Pandemic on Primary or Revision Total Hip and Knee Arthroplasty—A Cross-Sectional Single Center Study. J. Clin. Med. 2021, 10, 1260. https://doi.org/10.3390/jcm10061260

AMA Style

Simon S, Frank BJH, Aichmair A, Manolopoulos PP, Dominkus M, Schernhammer ES, Hofstaetter JG. Impact of the 1st and 2nd Wave of the COVID-19 Pandemic on Primary or Revision Total Hip and Knee Arthroplasty—A Cross-Sectional Single Center Study. Journal of Clinical Medicine. 2021; 10(6):1260. https://doi.org/10.3390/jcm10061260

Chicago/Turabian Style

Simon, Sebastian, Bernhard J.H. Frank, Alexander Aichmair, Philip P. Manolopoulos, Martin Dominkus, Eva S. Schernhammer, and Jochen G. Hofstaetter. 2021. "Impact of the 1st and 2nd Wave of the COVID-19 Pandemic on Primary or Revision Total Hip and Knee Arthroplasty—A Cross-Sectional Single Center Study" Journal of Clinical Medicine 10, no. 6: 1260. https://doi.org/10.3390/jcm10061260

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop